This may result in reduced functionality and affect the graphical presentation of this site.However, all content will still be available.
For the vaccination of healthy horses 11 months of age or older, as an aid in the reduction of clinical disease and viral shedding caused by equine influenza viruses of both the American and Eurasian lineages.
Administer a single 1 mL dose intranasally in one nostril. The dose is administered into the nasal passages with a special proprietary applicator.
1 Lunn DP, Steve Hussey S, et al. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. JAVMA. 2001:218(6):900-906.
2 Townsend HGG. Onset of protection against live-virus equine influenza challenge following vaccination of naive horses with a modified-live vaccine. Unpublished data.
3 AAEP Vaccination Guidelines available at www.aaep.org
Copyright © 2019 Intervet Inc., a subsidiary of Merck & Co., All Rights Reserved. Intervet Inc. d/b/a Merck Animal Health, Madison, NJ 07901